BioCentury
BioCentury
YouTubeLinkedInXRSS
ARTICLE | Distillery Therapeutics

Inhibiting IRF5 to treat lupus

By  BioCentury Staff
August 27, 2021 8:36 PM UTC

DISEASE CATEGORY: Autoimmune disease

INDICATION: Lupus...

BCIQ Company Profiles

Yokohama City University

BCIQ Target Profiles

Interferon alpha and beta receptor 1 (IFNAR1) (IFNAR)

Interferon regulatory factor 5 (IRF5)

BCIQ Company Profiles

Yokohama City University

BCIQ Target Profiles

Interferon alpha and beta receptor 1 (IFNAR1) (IFNAR)

Interferon regulatory factor 5 (IRF5)

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
YouTubeLinkedInXRSS
BioCentury
© 2025 BioCentury Inc. All Rights Reserved.
Copyright © 2025 BioCentury Inc. All Rights Reserved.
YouTubeLinkedInXRSS